In Vitro Diagnostics Quality Control Market by Top Companies And Forecast Report By 2026Posted by Manisha S on November 21st, 2022 The global IVD quality control market size is expected to reach USD 1.24 billion by 2026, according to a new report by Grand View Research, Inc. The market is projected to witness a CAGR of 4.1% over the forecast period. Continually evolving technology-oriented changes in the diagnostics field and growing need to ensure patient safety necessitate the implementation of quality assurance programs in various medical disciplines including radiology and Point-of-Care (PoC) devices. Patients rely on self-testing IVD devices for long-term disease management and hence it is important for such devices to be checked, in terms of result reproducibility and validity, to guarantee patient safety.
Further key findings from the study suggest: • In 2018, the clinical chemistry was the second-largest application segment of the global IVD market, in terms of market share • Demand for preventive medicine and rapid transformation of clinical laboratories into highly automated and efficient businesses are some of the factors for the segment’s growth • Molecular diagnostics is projected to be the fastest-growing segment due to increasing technical complexity of molecular diagnostic testing and need for quality evaluation to ensure standards • These tests are of prime importance as the outcomes enable healthcare practitioners make critical treatment decisions • Hospitals was the largest segment in 2018 due to the presence of advanced technology-based devices like Next Generation Sequencing (NGS) and microarrays, and rising applications of the optimized quality-control procedures • North America was the dominant regional market in 2018 due to the presence of over 150,000 registered diagnostics labs and is likely to maintain the dominance throughout the forecast years • Siemens Healthcare GmbH; Roche Diagnostics; Alere, Inc.; Abbott Laboratories, Inc.; Qiagen N.V.; Bio-Rad Laboratories, Inc.; Quidel Corp.; Becton, Dickinson and Company; bioMerieux, Inc.; Sysmex Corp.; Sero AS; and Thermo Fisher Scientific, Inc. are some of the key companies in the global market The global In Vitro Diagnostics (IVD) and IVD quality control market combines to account for USD 112.79 billion in revenue in 2021, which is expected to reach USD 114.73 billion by 2030, growing at a cumulative rate of 0.2% over the forecast period. In Vitro Diagnostics Quality Control Market Segmentation: Grand View Research has segmented the global IVD quality control market on the basis of application, type, end use, and region:
• Immunochemistry • Hematology • Clinical Chemistry • Molecular Diagnostics • Coagulation • Microbiology • Others IVD Quality Control Type Outlook (Revenue, USD Million, 2014 – 2026) • Quality Control
• Quality Assurance Services
• Data Management
IVD Quality Control End Use Outlook (Revenue, USD Million, 2014 – 2026) • Hospitals • Laboratories • Home-care • Others IVD Quality Control Regional Outlook (Revenue, USD Million, 2014 – 2026) • North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
Order a free sample of this Intelligence study @ https://www.grandviewresearch.com/sector-report/in-vitro-diagnostics-ivd-quality-control-industry-data-book/request/rs1 Like it? Share it!More by this author |